Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program
SHANGHAI,Jan. 6,2025-- Asieris Pharmaceuticals (Stock Code: 688176.SH),a leading global biopharmaceutical company dedicated to advancing innovative therapies for genitourinary tumors and women\'s heal